Literature DB >> 1888692

Effect of the acute sublingual administration of ketanserin in hypertensive patients.

G Aliberti1, E D'Erasmo, C M Oddo, E Vecci.   

Abstract

The purpose of this study has been to compare the acute antihypertensive effect of a dose of 20 mg of ketanserin in 18 patients after sublingual administration and in 19 after oral administration. In three patients ketanserin and ketanserin-ol plasma levels were measured after both sublingual and oral administration. The results showed a more rapid, considerable antihypertensive effect after sublingual administration. In addition, the high plasma levels of ketanserin-ol, the metabolite produced by hepatic reduction of ketanserin, reached after sublingual administration, rather than transmucosal absorption, indicate that the clinical effect observed is due to more rapid dissolution of the tablet formulation and liberation of the active drug.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1888692     DOI: 10.1007/bf03029743

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  8 in total

1.  Bioavailability and pharmacokinetics of ketanserin in elderly subjects.

Authors:  M Kurowski
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Pharmacokinetics of ketanserin in man.

Authors:  I W Reimann; P O Okonkwo; U Klotz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Acute effects of ketanserin on left ventricular function, metabolism and coronary blood flow.

Authors:  J M Walker; P T Wilmshurst; S M Juul; D J Coltart
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

4.  Mechanism of the hypotensive effect of ketanserin.

Authors:  J R Fozard
Journal:  J Cardiovasc Pharmacol       Date:  1982 Sep-Oct       Impact factor: 3.105

5.  High-performance liquid chromatographic assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S2 antagonist in human plasma, blood and urine.

Authors:  P O Okonkwo; I W Reimann; R Woestenborghs; U Klotz
Journal:  J Chromatogr       Date:  1983-02-11

6.  Ketanserin in essential hypertension: effects during rest and exercise.

Authors:  B Persson; T Hedner; G Berglund
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Controlled trial of ketanserin in hypertension.

Authors:  J C McGourty; J H Silas; K J Cowen
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

8.  5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.

Authors:  G J Wenting; A J Woittiez; A J Man in't Veld; M A Schalekamp
Journal:  Hypertension       Date:  1984 Jan-Feb       Impact factor: 10.190

  8 in total
  1 in total

Review 1.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.